
Tempus AI Skyrockets Amidst Bold New Partnership in Cancer Treatment
Tempus AI, Inc.’s share price jumped nearly 30% in a week, highlighting its prominence in the stock market. The company has formed a strategic alliance with the Institute for Follicular Lymphoma Innovation (IFLI) to advance cancer treatment using AI. The partnership focuses